CRSP THERAPEUTICS

CH0334081137 · CRSP (NGM)

0 value funds · 3 CNMV managers

1-year price history

Source: Yahoo Finance

The chart uses daily closes adjusted by the available provider. There may be delays, gaps or differences versus the official source.

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Healthcare · Biotechnology
https://www.crisprtx.com

Value funds holding it

Of the value funds we track closely. A different universe and period from "CNMV managers": never added together.

See in Radar Fondos →

CNMV managers

4 → 3 (-1) · net presence change vs. previous period

See context in Radar Gestoras →

Funds (CNMV universe)

6 → 4 (-2) · net presence change vs. previous period

Avg. weight

0.90%

Price

—

Sector

Industry

CNMV data · half-year closed 2025-12-31.

No ticker identified yet: no price or market data for this ISIN.

Funds holding this company

CNMV period H2 2025. Weight is the sum of every instrument of the company that fund holds (local share, ADR or another class), not just one.

Fund Manager Weight

A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. 2.35% MERCH-EUROUNION, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. 0.74% PATRIVAL, FI PATRIVALOR, SGIIC, S.A. 0.27% PATRIBOND, FI PATRIVALOR, SGIIC, S.A. 0.23%

Company-level moves

Compares H1 2025 with H2 2025, summing every instrument of the company each fund holds. A fund switching instrument within the same company doesn't show up here as an entry or exit — for that instrument-by-instrument detail, see the Instruments section.

New positions: 0 Exits: 2 Increasing exposure: 0 Reducing exposure: 4

− GESTION BOUTIQUE IV, FI

Leaves the position; it weighed 3.51%.

− TOP CLASS HEALTHCARE, FI

Leaves the position; it weighed 0.77%.

Objective ratios

Not enough financial data on Yahoo Finance to calculate ratios for this company.

Disclaimer

This is not financial advice. Weights come from the periodic reports each manager files with the CNMV and lag the real close of the period. Price, description and ratios, when available, come from Yahoo Finance and may not exactly match this ISIN if the company has multiple share classes.